Mengmeng Dou

751 total citations
31 papers, 597 citations indexed

About

Mengmeng Dou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mengmeng Dou has authored 31 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mengmeng Dou's work include Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Mengmeng Dou is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Epigenetics and DNA Methylation (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Mengmeng Dou collaborates with scholars based in China, Norway and United States. Mengmeng Dou's co-authors include Xiaoyan Zhao, Xueliang Zhou, Lifeng Li, Duoduo Zhang, Zhubo Li, Jie Zhang, Weijie Zhang, Lin Zhu, Liuxing Wang and Yaojuan Chu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Mengmeng Dou

30 papers receiving 591 citations

Peers

Mengmeng Dou

PRM

PHARM

ONCOL

Dujuan Xu China

Jasmin Shafarin United Arab Emirates

Zibin Lu China

Veronica Cocetta Italy

Jiahong Chen China

Yu‐Ning Lin Taiwan

Yinggang Sun China

Wei‐Jan Wang Taiwan

Jaime Jacqueline Jayapalan Malaysia

Dujuan Xu China

Mengmeng Dou

354 ×1.1

93 ×0.9

76 ×0.8

PRM

71 ×0.9

PHARM

96 ×1.4

ONCOL

Citations per year, relative to Mengmeng Dou Mengmeng Dou (= 1×) peers Dujuan Xu

Countries citing papers authored by Mengmeng Dou

Since Specialization

Citations

This map shows the geographic impact of Mengmeng Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengmeng Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengmeng Dou more than expected).

Fields of papers citing papers by Mengmeng Dou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengmeng Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengmeng Dou. The network helps show where Mengmeng Dou may publish in the future.

Co-authorship network of co-authors of Mengmeng Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Mengmeng Dou. A scholar is included among the top collaborators of Mengmeng Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengmeng Dou. Mengmeng Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jin, Xin, Wendi Ma, Wenying Li, et al.. (2025). Oxymatrine regulates microglia to produce IFN-β by activating the STING/TBK1/IRF3 pathway against experimental autoimmune encephalomyelitis. European Journal of Pharmacology. 1009. 178380–178380.

Li, Xinyu, Wenbin Wang, Mengmeng Dou, et al.. (2024). Matrine protects against experimental autoimmune encephalomyelitis through modulating microglial ferroptosis. Biochemical and Biophysical Research Communications. 735. 150651–150651. 4 indexed citations

Dou, Mengmeng, Yaojuan Chu, Xueliang Zhou, et al.. (2023). Matrine Mediated Immune Protection in MS by Regulating Gut Microbiota and Production of SCFAs. Molecular Neurobiology. 61(1). 74–90. 6 indexed citations

Chu, Yaojuan, Mengmeng Dou, Xiaoyu Zhao, et al.. (2022). Matrine inhibits the Wnt3a/β-catenin/TCF7L2 signaling pathway in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 367. 577876–577876. 10 indexed citations

Zhang, Di, Wei Liu, Mengmeng Dou, et al.. (2022). Salvia miltiorrhiza polysaccharides ameliorates Staphylococcus aureus-induced mastitis in rats by inhibiting activation of the NF-κB and MAPK signaling pathways. BMC Veterinary Research. 18(1). 201–201. 15 indexed citations

Zhou, Xueliang, Mengmeng Dou, Zaoqu Liu, et al.. (2021). Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma. Journal of Immunology Research. 2021. 1–20. 8 indexed citations

Zhou, Xueliang, Wenguang Zhang, Mengmeng Dou, et al.. (2021). 125I seeds inhibit proliferation and promote apoptosis in cholangiocarcinoma cells by regulating the AGR2-mediated p38 MAPK pathway. Cancer Letters. 524. 29–41. 17 indexed citations

Chu, Yaojuan, et al.. (2021). Matrine treatment induced an A2 astrocyte phenotype and protected the blood-brain barrier in CNS autoimmunity. Journal of Chemical Neuroanatomy. 117. 102004–102004. 20 indexed citations

Dou, Mengmeng, Xueliang Zhou, Lifeng Li, et al.. (2021). Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS. Frontiers in Immunology. 12. 640778–640778. 9 indexed citations

10.

Zhou, Xueliang, Dechao Jiao, Mengmeng Dou, et al.. (2020). Brachytherapy Combined With or Without Hormone Therapy for Localized Prostate Cancer: A Meta-Analysis and Systematic Review. Frontiers in Oncology. 10. 169–169. 1 indexed citations

11.

Wang, Meng‐Ru, Xiaojian Zhang, Hongchun Liu, et al.. (2019). Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy. Brain Research Bulletin. 153. 30–38. 29 indexed citations

12.

Zhou, Xueliang, Mengmeng Dou, Jianjian Chen, et al.. (2019). Association of glutathione-S-transferase p1 gene promoter methylation and the incidence of prostate cancer: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 145(8). 1939–1948. 11 indexed citations

13.

Fan, Zhirui, Wenhua Xue, Mengmeng Dou, et al.. (2018). Bushenshugan Formula Attenuates the Development of Lung Cancer by Inhibiting Epithelial-Mesenchymal Transition. Cellular Physiology and Biochemistry. 47(5). 1977–1988. 6 indexed citations

14.

Dou, Mengmeng, Xueliang Zhou, Zhirui Fan, et al.. (2018). Clinical Significance of Retinoic Acid Receptor Beta Promoter Methylation in Prostate Cancer: A Meta-Analysis. Cellular Physiology and Biochemistry. 45(6). 2497–2505. 9 indexed citations

15.

Dou, Mengmeng, Zhirui Fan, Yuxuan Zhang, et al.. (2017). Reproductive Hormones and Their Receptors May Affect Lung Cancer. Cellular Physiology and Biochemistry. 44(4). 1425–1434. 24 indexed citations

16.

Huang, Jian, et al.. (2017). Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls. Scientific Reports. 7(1). 1207–1207. 21 indexed citations

17.

Chen, Qicong, Xu Liu, Mengmeng Dou, et al.. (2016). Genetic Association of CHAT rs3810950 and rs2177369 Polymorphisms with the Risk of Alzheimer’s Disease: A Meta-Analysis. BioMed Research International. 2016. 1–12. 12 indexed citations

18.

Zhang, Zhihao, Duoduo Zhang, Mengmeng Dou, et al.. (2016). Dendrobium officinale Kimura et Migo attenuates diabetic cardiomyopathy through inhibiting oxidative stress, inflammation and fibrosis in streptozotocin-induced mice. Biomedicine & Pharmacotherapy. 84. 1350–1358. 65 indexed citations

19.

Zhang, Zhihao, et al.. (2016). Potential Biomarkers in Diagnosis of Human Gastric Cancer. Cancer Investigation. 34(3). 115–122. 11 indexed citations

20.

Li, Peichun, et al.. (2014). Synergic effects of artemisinin and resveratrol in cancer cells. Journal of Cancer Research and Clinical Oncology. 140(12). 2065–2075. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact